Submit an Article

Interventional Oncology 360 will consider for publication suitable articles on topics pertaining to minimally invasive cancer therapies. For questions about submitting an article, contact  managing editor, Lauren LeBano at llebano@naccme.com

Publication Ethics and Guidelines for Submitting Clinical Articles (pursuant to COPE publication ethics guidelines and the ICMJE guidelines)

Please include the following statement in the submission email: “The undersigned author transfers all copyright ownership of the manuscript entitled (title of article) to HMP Communications in the event the work is published. The author warrants that the article is original, is not under consideration by another journal, and has not been previously published. I sign for and accept responsibility for releasing this material on behalf of any and all co-authors.”

Review Process. All articles are reviewed by two or more referees. Acceptance is based upon significance and originality. Because the review is double blind, authors’ names should not appear in the text or on the figures. Editorial revisions may be made to articles accepted for publication as an aid to clarity.

Ethics. The author is responsible for the contents submitted in the paper. Opinions expressed by authors are their own and not necessarily those of HMP Communications, LLC, the editorial staff, or any member of the editorial advisory board. No claims made by authors or advertisers are guaranteed by the publisher or editors. Authors must comply with FDA guidelines, human studies guidelines and animal welfare regulations of the authors’ institution. Authors should indicate in the paper that human subjects have given informed consent and that the authors have conformed to institutional guidelines and those of the American Physiological Society.

Conflict of Interest/Disclosure. A statement acknowledging financial interest in products/companies relevant to submitted research must be disclosed to the editors when the paper is submitted. Any financial interest which may be interpreted as a conflict of interest, including stock ownership, consultancies, patent-licensing relationships, and other equity interests, must be disclosed in the cover letter. If no conflicts of interest exist, please state this.

Manuscript Format. All submissions to the journal should be in a digital format (.docx) and submitted by email to our editorial offices, attn: Lauren LeBano at llebano@naccme.com.  Figures can be in JPEG format or TIFF, please include figure legends in the document file (see more info in the figures/video section below).

Disclosure Statement. The title page should contain one of the following disclosure statements: (1) The authors report no financial relationships  or conflicts of interest regarding the content herein. (2) One or more of the authors have disclosed potential conflicts of interest regarding the content herein. (3) One or more of the authors has disclosed a potential conflict of interest that is not financial in nature.

Corresponding Author/Additional Authors. The corresponding author will receive all manuscript related correspondence via email.

Abstract. An abstract or summary is necessary for the review process. Depending on the type of article, it may or may not be published. For example, abstracts are not published for editorials or letters. For these types of articles, please provide a brief summary of less than 100 words. The abstracts or summaries are emailed to manuscript reviewers to help them determine if they have the expertise or interest in reviewing the article in question. For original articles and research studies, please provide a summary of less than 250 words. Abstracts can be included on the title page or on the next page.

Key Words. Please choose 2–3 words to be used in order to cross reference the subject of your manuscript with the expertise of the manuscript reviewers.

References. References should be listed at the end of the manuscript. Numbered references must be cited, in order in the text. A complete periodical reference includes 1) authors’ names (list all authors up to six, for seven or more authors, list first three followed by et al.); 2) title of article; 3) abbreviated journal name; 4) name of publisher; 5) year of publication; 6) volume number; 7) specific page numbers. For books include: 8) name of editor(s), if any; and 9) place of publication. For example:

  • Periodical: 8. O'Neill M, Rosenkrantz J, Salsamendi J, Venkat S, Bhatia S, Narayanan G. Diagnosis and endovascular treatment of common vascular complications in the post liver transplant patient: a pictorial essay. Vasc Dis Manag. 2013;10(9):E170-E178.
  • Book: 5. Mehta S. Textbook of STEMI Interventions. Malvern, Pennsylvania: HMP Communications, 2008.
  • Chapter in Book (author is not editor of the book): 3. Muller DWM. Restenosis: Site-specific therapy. In: Topol EJ (ed). Textbook of Interventional  Cardiology, 2nd edition. Philadelphia: W.B. Saunders Company, 1993:436–448. 

Figures and Videos. A descriptive legend must accompany each figure. All abbreviations must be identified in the figure legend. If a figure has been published previously, permission to reprint the figure  must be obtained in writing from the copyright owner and submitted upon acceptance. Please acknowledge the source beneath the figure. Digital figures may be provided in JPEG, TIFF or PowerPoint format, and may be as low as 72 d.p.i. resolution, which is sufficient for web-based publication. Videos can be provided in various formats (.avi is preferred) for web publication.